Skip to content

    Lupus Health Center

    Font Size

    Drug Shows Promise for Lupus Skin Conditions

    WebMD Health News
    Reviewed by Louise Chang, MD

    Dec. 7, 2012 -- A drug related to thalidomide may be more potent and less toxic than thalidomide, which is often used to treat lupus skin conditions.

    In a small study from Spain, lupus patients showed dramatic improvements in skin lesions while taking the drug, lenalidomide (Revlimid), and most relapsed soon after they stopped taking it.

    Thalidomide’s Infamous Past

    Thalidomide is best known as the drug that caused thousands of children to be born with missing limbs and other birth defects in the late 1950s and early 1960s.

    In more recent years it has been brought back to the market to treat a number of serious conditions, but its use is monitored closely to ensure that it is not taken by women who are pregnant or who might become pregnant.

    Dermatology professor Andrew G. Franks Jr., MD, of the NYU Langone Medical Center, says thalidomide is very effective for treating people with lupus skin conditions who do not respond to standard treatments such as steroids and antimalarial drugs.

    He says about 75% of patients with affected skin will go into remission with these standard treatments.

    “The question has been, ‘What do you do with the rest?’” he says.

    Franks says thalidomide can help an additional 75% of patients achieve remission. But side effects are common and some, including nerve damage in the hands and feet, can be permanent.

    Lenalidomide Highly Effective in Small Study

    The lenalidomide study included 15 women with lupus skin conditions; six had lupus in other areas of the body, too. They all were followed for seven to 30 months.

    All had received standard treatments, and 14 had been treated with thalidomide previously.

    The majority of the patients (60%) had the most common subtype of lupus-related skin disease, known as discoid lupus erythematosus, which is characterized by red, scaly patches that can scar.

    One patient withdrew from the study after one week due to digestive system side effects. All the other patients showed improvement, and the rash cleared up in 86%.

    The researchers note that the study dose was “generally well-tolerated.” No new nerve symptoms were reported.

    Similar to treatment with thalidomide, most of the patients had a relapse of their skin problems within weeks of stopping the drug.

    Today on WebMD

    grocery shopping list
    And the memory problems that may come with it.
    Lupus rash on nails
    A detailed, visual guide.
    sunburst filtering through leaves
    You might be extra sensitive to UV light. Read on.
    fruit drinks
    For better focus in your life.
    Woman rubbing shoulder
    Bag of cosmetics
    young woman hiding face
    pregnant woman
    5 Lupus Risk Factors
    Young adult couple
    doctor advising patient
    sticky notes on face

    WebMD Special Sections